{
  "drop_bad_rows": {"colname": "suppressed_flag"},
  "clean_geography_type": {"colname": "geography_label"},
  "clean_geography": {"override": "nation"},
  "clean_domain_type": {"override": "age & season"},
  "clean_domain": {"overide": "adult females aged 18-49 years with infants under the age of 8 months during the RSV season (born since April 1, 2024)"},
  "clean_indicator_type": {"override": "4-level vaccination and intent"},
  "clean_indicator": {"colname": "indicator_category_label"},
  "clean_vaccine": {
        "donor_colname": "indicator",
        "transfer":{
                "nirsevimab for infant": "nirsevimab",
                "infant nirsevimab": "nirsevimab",
                "Infant received nirsevimab": "nirsevimab",
                "Mother received": "rsv_maternal",
                "The mother received": "rsv_maternal",
                "RSV vaccine": "rsv"
            }
    },
  "clean_time_type": {"override": "month"},
  "clean_time_start_end": {
        "colname": "timeframe",
        "col_format": "both",
        "time_format": "%m/%d/%Y"
    },
  "clean_estimate": {"colname": "estimate"},
  "clean_lci_uci": {
        "colname": "_95_confidence_interval",
        "col_format": "full"
    },
  "clean_sample_size": {"colname": "sample_size"},
  "remove_duplicates": {}
}